Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
Journal of Computer Assisted Tomography|July 1, 1993
CT and MR accuracy in the detection of tumor recurrence in patients treated for ovarian cancerL Prayer, C Kainz, J Kramer, et al.
Breast Cancer Research and Treatment|September 24, 2002
The clinical value of preoperative wire localization of breast lesions by magnetic resonance imaging--a multicenter studyD Lampe, L Hefler, T Alberich, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|August 31, 2021
Does preoperative locally applied estrogen treatment facilitate prolapse-associated symptoms in postmenopausal women with symptomatic pelvic organ prolapse? A randomised controlled double-masked, placebo-controlled, multicentre studyM-L Marschalek, K Bodner, O Kimberger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2010
Epirubicin and cyclophosphamide versus epirubicin and docetaxel as first-line therapy for women with metastatic breast cancer: final results of a randomised phase III trialJ-U Blohmer, P Schmid, J Hilfrich, et al.
International Urogynecology Journal and Pelvic Floor Dysfunction|May 6, 2005
Updated recommendations on ultrasonography in urogynecologyR Tunn, G Schaer, U Peschers, et al.
Gynecologic Oncology|January 29, 2008
Role of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (PAI-1) for prognosis in endometrial cancerE Steiner, K Pollow, D Hasenclever, et al.
Minerva Ginecologica|February 16, 2013
Different surgical approaches for stress urinary incontinence in womenJ Mischinger, B Amend, C Reisenauer, et al.
Neurourology and Urodynamics|December 22, 2009
Pelvic organ prolapse and overactive bladderT A de Boer, S Salvatore, L Cardozo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 1, 2008
Long-term outcome prediction by clinicopathological risk classification algorithms in node-negative breast cancer--comparison between Adjuvant!, St Gallen, and a novel risk algorithm used in the prospective randomized Node-Negative-Breast Cancer-3 (NNBC-3) trialM Schmidt, A Victor, D Bratzel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 19, 2002
A randomized double-blind multicenter phase III study of fixed-dose single-administration pegfilgrastim versus daily filgrastim in patients receiving myelosuppressive chemotherapyM D Green, H Koelbl, J Baselga, et al.
Pageof 9